Ua hoʻokumu ʻo Graphene Leaders Canada Inc. i ka GLC Medical Inc. i kahi hopena Covid-19.
Ua ʻike ʻo GLC Medical Inc. i kahi hōʻike diagnostics wikiwiki (ma lalo o 1 mau minuke) i ke alo o SARS-CoV-2. Hoʻopau kēia mea hoʻohana hope ʻana i ka pono no ka nasopharyngeal swab ke hoʻohana mākou i ka saliva ma ke ʻano o ka laʻana. Me ka ʻole o ka mea lapaʻau, ʻo kēia hoʻāʻo ʻana o ka mālama ʻana e hōʻemi i ka pilikia o ka hoʻopaʻa ʻana i ke keʻa a hāʻawi i ka poʻe i ka maluhia o ka noʻonoʻo i ka ʻoluʻolu o ko lākou home, a i ʻole "ma ka puka" o kā lākou wahi leʻaleʻa punahele a i ʻole kekahi wahi e koi ai. kaʻawale kaiapuni.
Ua hoʻopau ʻo GLCM i ka hoʻomohala ʻana i ka sensor hoʻonui graphene i hoʻohana ʻia i ka pahu hoʻāʻo wikiwiki, ʻo ia hoʻi i-vitro mea hoʻokalakupua kēlā pahu, ʻo ia hoʻi he i-vitro mea diagnostic e hana ana i kahi hōʻailona ke ʻike ʻia i nā antigens viral COVID-19. Me ka loaʻa ʻana o ka ʻike kūpono o nā antigens viral, ua hoʻomaka ʻo GLCM i ka hoʻomohala ʻana i kahi prototype hana o ka hoʻāʻo pane wikiwiki. Manaʻo ʻo GLCM e pōmaikaʻi mai nā koi hoʻoponopono wikiwiki a me nā koi hoʻāʻo lapaʻau e like me ka mea i hoʻolaha ʻia e kekahi mau keʻena hoʻoponopono e like me Health Canada a me ka United States 'FDA.
ʻO Graphene Leaders Canada (GLC) Inc. me ka hui ʻo GLC Medical (GLCM) Inc. hoʻolaha i kā lākou hoʻomohala ʻana i kahi sensor i hoʻonui ʻia i ka graphene no ka hoʻohana ʻana i kā lākou COVID-19 Rapid Test e hāʻawi pololei ana a hilinaʻi. nā hopena i kekona. keia mea ʻike hoʻonui graphene kākoʻo i ka wikiwiki a me ka maʻalahi e hoʻohana ʻO ka pahu hoʻāʻo ʻike maʻi maʻi COVID-19 wikiwiki a ʻo ia wale nō ka hoʻāʻo ʻana i ka saliva, e hoʻopau ana i ka swab nasopharyngeal, nā koi a pau i hōʻoia ʻia e ka practitioner kiaʻi, ʻaʻole koi i nā lako makamae, ʻaʻohe hoʻopaʻa keʻa e hoʻonui ai i nā contaminations keʻa. ʻIke pololei ka hoʻāʻo a GLCM i ka maʻi maʻi me ka hōʻoia ʻana ʻaʻole nā hopena maikaʻi a maikaʻi ʻole, ʻaʻole like me nā hoʻāʻo ʻē aʻe e ʻike wale i nā hopena o ka maʻi a no laila ʻaʻole hilinaʻi.
ʻO COVID-19 o GLCM hōʻike kiko-o-mālama e hāʻawi i kahi pono kūʻokoʻa ma mua o nā hoʻokolohua ʻē aʻe e ʻike ai i ka hele ʻana o ka maʻi COVID-19. I kēia lā, ʻo nā hoʻokolohua hoʻokūkū ʻē aʻe i hoʻolaha ʻia he mau hoʻokolohua nucleic acid a me nā hoʻokolohua serological essay. Hoʻolālā ʻia nā hoʻokolohua serological assay e ʻike i nā antibodies IgM a me IgG i kēia manawa ma hope o ka maʻi. ʻIke ʻia nā hoʻāʻo nucleic acid i ka maʻi maʻi, akā naʻe, pono ke hoʻohana ʻana i ka nasopharyngeal swab a pono e unuhi ʻia nā hopena e ke kauka i hōʻoia ʻia e hoʻohana ana i nā lako makamae he hana lohi. Hoʻopuka nā hoʻokolohua serological a me nā nucleic i nā hopena maikaʻi ʻole a me nā hopena maikaʻi ʻole, ʻoiai ua kūkulu ʻia ka hoʻāʻo ʻana o GLCM e hōʻike i kahi hopena maikaʻi wale nō ke loaʻa ka maʻi COVID-19, e ʻae ana i ka wehewehe pololei a maopopo e ka mea hoʻohana.
Ua hōʻike ʻo Jason Deacon, Product Development Lead o GLC-GLCM, "ʻO Graphene ka mea ʻike kūpono. ʻO ke ʻano 2D a me nā ʻano conductive o ka graphene e hana i nā mea koʻikoʻi loa e ʻike i kekahi mole. Ua noiʻi nui au i kēia kumuhana i koʻu wā ma ke Kulanui ʻo Cambridge. Ma GLC-GLCM, ua hana mākou i ka ʻili i kikoʻī loa i ka SARS-CoV-2 (COVID-19) e hōʻoia i kā mākou hoʻokolohua wikiwiki e hoʻopakele i nā ola. Ua hoʻopaʻa ʻia ke aʻo ʻana o nā mea 2D i ke kula no 15 mau makahiki. Manaʻo kā mākou hui ma GLC-GLCM he mea koʻikoʻi ka nanotechnology e pili ana i nā mea 2D i ka ʻenehana a me ka hana hou, me ka graphene ma mua.
ʻO ka hoʻāʻo wikiwiki ʻana o GLCM he ʻenehana "ma ka puka" kūpono loa ma mua o ke kau ʻana i ka mokulele, ke komo ʻana i kahi wahi no ka ʻaha mele a i ʻole ka hanana haʻuki, no ka mea, hāʻawi ia i nā hopena koke e loaʻa hou ai ka hilinaʻi e hoʻihoʻi iā mākou i kā mākou "maʻamau" ma mua o ka maʻi maʻi.
Ke hoʻomau nei ka Hui i nā kūkākūkā me nā mea hana a me nā aupuni i kekahi mau ʻāina i mea e hoʻomaʻamaʻa i nā protocols hana e hōʻike ana i nā koi hoʻokō hoʻoponopono aupuni o ko lākou ʻāina.
Ua ʻōlelo ʻo Donna Mandau, Pelekikena a me Luna Nui no GLC-GLCM, "ʻO ka kūleʻa o kēia hoʻomohala e hāʻawi i ka honua i kahi hopena no COVID-19, a no ka mea hiki ke hoʻohālikelike ʻia kā mākou graphene, hiki iā mākou ke hāʻawi i kahi hopena wikiwiki i ka maʻi virus e hiki mai ana i ka hoʻololi wikiwiki ʻana o kā mākou. graphene e hōʻoiaʻiʻo ʻaʻole mākou e hoʻihoʻi i ka pani waiwai nui e like me ka COVID-19. ʻO ka hoʻoikaika ʻana iā mākou a pau ma GLC-GLCM e hāʻawi i kā mākou graphene solutions no Kanaka a me ka Honua. Hoʻopili kēia hoʻokolohua wikiwiki i ka ʻohana a me nā hoaaloha no nā manawa hauʻoli me ka makaʻu ʻole iā COVID-19. Hoʻohui pū kēia hoʻāʻo i ka ʻohana i kēlā mau manawa e pono ai mākou e ʻōlelo aloha i kahi mea aloha. ʻAʻole pono kekahi e make mehameha hou."
ʻO Graphene Leaders Canada (GLC) Inc. he hui ʻenehana Kanada e hana ana i nā nanomaterials graphene kiʻekiʻe, maʻemaʻe kiʻekiʻe e hana ana ma ke ʻano he ʻenehana platform me ka hiki ke hoʻohui i ka waiwai ma nā noi he nui. Hoʻokumu ʻia ʻo Graphene Leaders Canada Inc. e hana pū me ka ʻoihana e hoʻomohala i nā hopena ma o ka hoʻohui ʻana i ka graphene e hoʻomohala i nā huahana hou.
ʻO ka laina hōʻailona o GLC "Hana ʻana i nā huahana maikaʻi loa".
He lālā ʻo GLC Medical (GLCM) Inc. no GLC Inc. a hāʻawi i nā ʻōnaehana graphene i ka ʻoihana lapaʻau e hoʻohana ana i kā mākou ʻike ʻepekema waiwai i ka hana ʻana me ka graphene kiʻekiʻe a me ka hoʻomohala ʻana i nā huahana a me nā hoʻonā e lawelawe i ka maikaʻi o People a me Planet.
He aha e lawe ʻia mai kēia ʻatikala:
- GLCM completed the development of the graphene-enhanced sensor used in the rapid test kit, which is an in-vitro diagnostic device that kit, which is an in-vitro diagnostic device that produces a signal when exposed to COVID-19 viral antigens.
- Without the need of a specialist, this point-of-care test reduces the risk of cross-contamination and gives people peace of mind in the comfort of their home, or “at the door”.
- Both the serological and the nucleic tests produce false positive and false negative results, whereas GLCM’s test has been developed to indicate a positive result only when the COVID-19 virus is present, allowing for direct and clear interpretation by the user.
